We enable nucleic acid labeling bioconjugation
Generic selectors
Exact matches only
Search in title
Search in content
product_variation

BCV-193N was positively assessed in the Scientific Advice Meeting

BCV-193N was positively assessed in the Scientific Advice Meeting

Coronavirus vaccine development at baseclick Vaccine GmbH

Neuried, Germany, October 29th, 2021 – the German company baseclick Vaccine GmbH presented its preclinical data to the Paul Ehrlich Institute in a Scientific Advice Meeting, the outline for the production of its sugar-modified mRNA vaccine and phase I clinical study.

>>Read press release english (PDF)

>>Read press release german (PDF)